Suppliers in Kansas City, MO
90 Medicare Suppliers found. Showing 1 - 20
 Medline Industries, Inc Durable Medical Equipment & Medical Supplies Location: 1401 Universal Ave, Kansas City, Missouri 64120 Phone: (816) 483-1083 |
Cvs Pharmacy #08556 Durable Medical Equipment & Medical Supplies Location: 5440 Nw 64th St, Kansas City, Missouri 64151 Phone: (816) 741-5576 |
Cvs Pharmacy #08577 Pharmacy Location: 4400 Nw Barry Rd, Kansas City, Missouri 64154 Phone: (816) 587-8018 |
Cvs Pharmacy #08578 Durable Medical Equipment & Medical Supplies Location: 6300 Prospect Ave, Kansas City, Missouri 64132 Phone: (816) 444-2922 |
|
Cvs Pharmacy #08553 Medicare Supplier Location: 10205 State Line Rd, Kansas City, Missouri 64114 Phone: (816) 942-0134 |
Cvs Pharmacy #08609 Durable Medical Equipment & Medical Supplies Location: 7003 Bannister Rd, Kansas City, Missouri 64134 Phone: (816) 761-7715 |
Cvs Pharmacy #08576 Durable Medical Equipment & Medical Supplies Location: 2435 E Independence Ave, Kansas City, Missouri 64124 Phone: (816) 483-6464 |
Cvs Pharmacy #08571 Pharmacy Location: 4750 Lees Summit Rd, Kansas City, Missouri 64136 Phone: (816) 350-3886 |
Cvs Pharmacy #08592 Durable Medical Equipment & Medical Supplies Location: 921 Main, Kansas City, Missouri 64105 Phone: (816) 842-2514 |
Cvs Pharmacy #08590 Pharmacy Location: 315 W 75th St, Kansas City, Missouri 64114 Phone: (816) 361-4639 |
Cvs Pharmacy #08594 Community/Retail Pharmacy Location: 5901 Independence, Kansas City, Missouri 64125 Phone: (816) 231-2033 |
|
Cvs Pharmacy #08555 Durable Medical Equipment & Medical Supplies Location: 4990 Ne Vivion Rd, Kansas City, Missouri 64119 Phone: (816) 454-8800 |
Cvs Pharamcy #08565 Durable Medical Equipment & Medical Supplies Location: 330 Ne Barry Rd, Kansas City, Missouri 64155 Phone: (816) 436-5600 |
Cvs Pharmacy #05635 Pharmacy Location: 11124 Holmes Rd, Kansas City, Missouri 64131 Phone: (816) 942-3262 |
Cvs Pharmacy #05724 Pharmacy Location: 13101 State Line Rd, Kansas City, Missouri 64145 Phone: (816) 942-2438 |
Cvs Pharmacy #05678 Pharmacy Location: 7907 State Line Rd, Kansas City, Missouri 64114 Phone: (816) 444-2000 |
Cvs Pharmacy #05663 Pharmacy Location: 6244 Brookside Blvd, Kansas City, Missouri 64113 Phone: (816) 444-0444 |
Cvs Pharmacy #05624 Pharmacy Location: 4149n Oak Trfy, Kansas City, Missouri 64116 Phone: (816) 454-5541 |
News Archive
WSBI, University of Colorado sign licensing agreement for TCISM targets
Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.
New insight into reprogramming of cells
A discovery by Babraham scientists brings new insight into how cells are reprogrammed and a greater understanding of how the environment, or factors like nutritional signals, can interact with our genes to affect health. As an embryo develops, cells acquire a particular fate, for example becoming a nerve or skin cell. The findings, reported online in the journal Nature, pinpoint a protein called AID as being important for complete cellular reprogramming in mammals.
Biogen, Elan launch My MS Health, a web-based PRO research program
Biogen Idec and Elan Corporation, plc, in collaboration with EPI-Q, Inc. and Avatar International, LLC, today announced the launch of My MS Health, a first-of-its-kind, web-based, patient-reported outcomes research program. My MS Health is designed to track and provide instant reports on patient function and quality of life using validated measures over time.
FDA lifts clinical hold on Icagen's IND for ICA-105665 epilepsy drug candidate
Icagen, Inc. today announced that, following a review of data from recently completed clinical studies as well as the Company's proposed protocol for a Phase II clinical trial in patients with treatment resistant epilepsy, the FDA has notified the Company that the clinical hold on Icagen's IND for ICA-105665, a novel orally available small molecule KCNQ potassium channel agonist, has been removed.
› Verified 3 days ago